Tamara Visit 3: Patient with recent-onset type 2 diabetes, 10 weeks later

Curriculum:
N/A
Credits:
0.5 AMA PRA Category 1 Credits
Launch Date:
18-Sep-09
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No Primary Audience Was Provided.

Relevant Terms:

No Primary Audience Was Provided.

Robert E. Heinig, MD

Robert E. Heinig, MD
Clinical Professor of Medicine
University of Rochester Medical School
Chief of Endocrinology
Rochester General Hospital
Rochester, NY

After earning his BA in Chemistry at the University of Arizona and his MD at the Oregon Health Science University School of Medicine, Dr. Heinig completed his residency in Internal Medicine at Rochester’s Strong Memorial Hospital. Dr. Heinig is board-certified in Internal Medicine, Nephrology, and Endocrinology & Metabolism. He is a Clinical Professor of Medicine at the University of Rochester Medical School and serves as Chief of Endocrinology at Rochester General Hospital.

Arturo R. Rolla, MD

Arturo R. Rolla, MD
Assistant Clinical Professor of Medicine
Harvard Medical School
Assistant Clinical Professor of Medicine
Tufts University School of Medicine
Endocrinologist, Beth Israel Deaconess Medical Center
Boston, MA

Dr. Rolla earned his MD at the Facultad de Medicina of the Universidad Catolica de Cordoba, the oldest private university in Argentina. He completed his residency in Internal Medicine at New England Deaconess Hospital and fellowships in Endocrinology, Diabetes & Metabolism at New England Deaconess Hospital and Joslin Diabetes Center. Dr. Rolla is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. He speaks four languages and currently serves as Assistant Clinical Professor of Medicine at both Harvard Medical School and Tufts University School of Medicine in addition to seeing patients at Beth Israel Deaconess Medical Center in Boston.

Jerry P. Palmer, MD

Jerry P. Palmer, MD
Professor of Medicine
University of Washington
Director, Department of Endocrinology
VA Puget Sound Health Care System
Seattle, WA

Dr. Jerry Palmer is Professor of Medicine at the University of Washington, Director of the Division of Endocrinology, Metabolism and Nutrition at the Veterans Affairs Puget Sound Health Care System, and Director of the Diabetes Endocrinology Research Center (DERC) at the University of Washington. His research interests focus on type 1 diabetes and encompass both clinical/translational research and basic laboratory research. He was director of the DCCT clinical center and currently directs the DCCT/EDIC and the TRIGR clinical centers at the University of Washington. He is actively involved in TrialNet and directs the beta-cell function and the cellular immunoblotting core laboratories for this organization. His basic science laboratory, which previously focused on autoantibodies as markers of the type 1 diabetes (T1DM) disease process and was first to identify insulin autoantibodies in the preclinical period of T1DM, currently focuses on T-cell reactivity to islet antigens in T1DM. He is especially interested in type 1.5 diabetes or LADA, the autoimmune diabetes that occurs in patients with many of the characteristics of type 2 diabetes. He is a member of the ASCI and the AAP and currently sits on the NIDDK advisory council. He has been an associate editor of Diabetes, on the editorial boards of Diabetes Care and the Journal of Clinical Endocrinology and Metabolism, and is very frequently asked to review grants and manuscripts nationally and internationally. Because of his long-term interest in the prediction and more recently the prevention of T1DM, he is chairman of the protocol committee for the GAD vaccination prevention study that will be performed by TrialNet and is Principal Investigator of the recently initiated United States registration trial of GAD vaccination in recently diagnosed T1DM patients.

Amy Campbell, MS, RD, LDN, CDE

Amy Campbell, MS, RD, LDN, CDE
Manager
Clinical Education Programs, Healthcare Services
Joslin Diabetes Center
Boston, MA

Amy Campbell, MS, RD, LDN, CDE, has been working at Joslin Diabetes Center in Boston since 1995, in the role of Diabetes and Nutrition Educator. She has a Bachelor of Science in Nutrition from Simmons College in Boston, and a Master of Science in Nutrition Education from Boston University.  Ms. Campbell did her Dietetic Internship at Deaconess Hospital in Boston, and has received a Certificate of Training in Adult Weight Management by the American Dietetic Association.  In addition to being a Registered Dietitian, she is a Certified Diabetes Educator. 

Ms. Campbell is a member of many organizations, including the American Heart Association Council on Nutrition, Physical Activity & Metabolism.  She is also actively involved in the education initiatives at Joslin and at the American Association of Diabetes Educators, the American Dietetic Association, and the American Diabetes Association. She has published articles for the layperson and professionals on nutrition topics, diabetes, cardiovascular disease, and obesity management.  She is also coauthor of 16 Myths of a "Diabetic Diet", for which she received the Will Solimene Award of Excellence in Medical Communication and the 2000 National Health Information Award.

Enrique Caballero, MD

Medical Director/Senior Editor:
Enrique Caballero, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Medical Affairs, Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA

Enrique Caballero, MD, is Director of Medical Affairs for Professional Education and a practicing physician in the Joslin Clinic, and an Assistant Professor of Medicine at Harvard Medical School. His CME responsibilities include project development, oversight of educational content, core slide development for educational activities, and oversight of activity evaluation and Educational Impact Assessments. He is a nationally and internationally known speaker on clinical diabetes, diabetes complications, and diabetes in minority populations, and has been a speaker at many live Joslin CME activities. Dr. Caballero has participated as a co-investigator for the National Diabetes Prevention Program (DPP) and the Action for Health in Diabetes (Look AHEAD) project, both supported by the National Institutes of Health, and has authored multiple original articles and book chapters. Dr. Caballero is a member of the American Diabetes Association, the Latin American Diabetes Association, and the European Association for the Study of Diabetes. Dr. Caballero also directs the Joslin Latino Diabetes Initiative and serves on the CME Advisory Committee.
1. Explain the natural history of type 2 diabetes including the evolution of insulin resistance and insulin secretory decline as key factors in the clinical progression of the disease
2. Recognize the role of the incretin system in normal physiology and in the pathophysiology and treatment of type 2 diabetes
3. Describe the process of selecting and advancing treatment regimens for type 2 diabetes in the outpatient setting that balance physiologic needs with individualized self-care considerations
4. List common obstacles to treatment advancement, including patient-based issues such as weight management issues, culture and self-care abilities, and clinician-based issues (such as office system inadequacy) that can contribute to therapeutic inertia
5. Choose appropriate tests and data collection to assist in the diagnosis of a patient with diabetes who is not at goal
6. Interpret test results, including lab values and glucose patterns, and analyze consulting reports from other clinicians, such as dietitians, diabetes educators, cardiologists, and ophthalmologists
7. Develop and implement office-based systems to manage treatment and facilitate therapeutic advancement